Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...

Olive-derived drugs could eventually find a place in your medicine cabinet as HonorHealth researchers explore their potential ...

A Stanford Medicine study reveals that dietary fiber is not just essential for good health, but it can also reduce cancer risk by influencing genetic activity.

ALX Oncology, a Bay Area biotech firm currently running clinical trials for its anticancer therapy, announced Wednesday that it’s laying off about 30% of its staff. ALX shared the news in a press ...

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

What are the key challenges in anticancer drug development, and how might they be addressed? The past three decades have seen spectacular advances in our understanding of the molecular and ...

This review of the literature affirms the role of prehabilitation in systemic anticancer therapy, and highlights how oncology nurses can impact outcomes of cancer treatment.

A bone marrow transplant process co-developed by investigators at the Johns Hopkins Kimmel Cancer Center is safe and curative for adults with sickle cell disease, according to results of a trial.

Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today the presentation of ...

This is thought to be a crucial step forward for researchers who are developing drugs to combat cancer and other diseases. with the Breaking Science News daily newsletter ...